欢迎您访问中乔新舟官网!400-038-9959我的购物车(0)
您当前的位置:首页 > 产品中心
KYSE-150人食管鳞癌细胞[套餐促销]
英文名:KYSE-150
货号:ZQ0449
价格:¥2000.00
加入购物车,提交订单信息之后,我们会第一时间与您取得联系!
推荐组合

KYSE-150人食管鳞癌细胞[套餐促销]

¥2000.00
+

KYSE-150人食管鳞癌细胞专用培养基

¥350.00 ¥480.00

配套完培,省时省力,单买细胞无优惠

=

细胞套餐惊爆价

¥2350 ¥2480.00
加入购物车
  • 产品说明
  • 产品规格
  • 参考文献
  • STR鉴定

产品名称

KYSE-150人食管鳞癌细胞

货号

ZQ0449

产品介绍

建立于49岁日本女性接受放射治疗后从上(颈)食管切除的低分化食管鳞状细胞癌(肿瘤侵入邻近结构);被描述为携带扩增的癌基因c-erb-B (8x)和细胞周期蛋白D1 (4x)并在裸鼠体内产生肿瘤。

种属

性别/年龄

女/49岁

组织

食道 

疾病

食管鳞状细胞癌

细胞类型

肿瘤细胞 

形态学

上皮的

生长方式

贴壁

倍增时间

大约13.7~25小时

培养基和添加剂

RPMI-1640(品牌:中乔新舟  货号:ZQ-200)+10%FBS(品牌:中乔新舟  货号:ZQ500-A+1%P/S(中乔新舟  货号:CSP006

推荐完全培养基货号

ZM0449

生物安全等级

BSL-1

STR位点信息

Amelogenin: X
D5S818:12,13
D13S317: 8,11
D7S820: 10,11
D16S539: 9,11
vWA: 16,17
TH01: 7,9
TPOX: 8
CSF1PO: 12,13
D19S433: 15,15.2
D21S11: 30,31
D18S51: 14 

培养条件

95%空气,5%二氧化碳;37℃

抗原表达/受体表达

 

基因表达

 

保藏机构

DSMZ; ACC-375

供应限制

仅供科研使用

货号

ZQ0449

发货规格

活细胞:T25培养瓶*1瓶或者1ml 冻存管*1支(细胞量约为5 x 10^5 cells/vial)二选一

发货形式

活细胞:常温运输;冻存管:干冰运输

储存温度

活细胞:培养箱;冻存管:液氮罐

产地

中国

供应限制

仅供科研使用


论文标题: PIWIL2 interacting with IKK to regulate autophagy and apoptosis in esophageal squamous cell carcinoma
DOI: 10.1038/s41418-020-00725-4
发表时间: 2021-01-19
期刊: CELL DEATH AND DIFFERENTIATION
影响因子: 15.828
货号: ZQ0449
产品名称: KYSE150 cells
原文链接: https://www.nature.com/articles/s41418-020-00725-4


论文标题: Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency
DOI: 10.3389/fonc.2022.871483
发表时间: 2022-05-12
期刊: Frontiers in Oncology
影响因子: 5.738
货号: ZQ0449
产品名称: KYSE150 cells

原文链接: https://www.frontiersin.org/articles/10.3389/fonc.2022.871483/full


论文标题: Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency
DOI: 10.1016/j.radonc.2020.06.022
发表时间: 2020-06-21
期刊: RADIOTHERAPY AND ONCOLOGY
影响因子: 4.856
货号: ZQ0449
产品名称: KYSE150 cells
原文链接: https://www.sciencedirect.com/science/article/pii/S0167814020303479


论文标题: MicroRNA-29b regulates the radiosensitivity of esophageal squamous cell carcinoma by regulating the BTG2-mediated cell cycle
DOI: 10.1007/s00066-021-01790-5
发表时间: 2021-07-07
期刊: STRAHLENTHERAPIE UND ONKOLOGIE
影响因子: 3.621
货号: ZQ0449
产品名称: KYSE150 cells
原文链接: https://link.springer.com/article/10.1007/s00066-021-01790-5


论文标题: miR-28-5p targets MTSS1 to regulate cell proliferation and apoptosis in esophageal cancer
DOI: 10.1093/abbs/gmaa059
发表时间: 2020-08-05
期刊: ACTA BIOCHIMICA ET BIOPHYSICA SINICA
影响因子: 2.836
货号: ZQ0449
产品名称: KYSE-150 cells
原文链接: https://academic.oup.com/abbs/article-abstract/52/8/842/5869218


论文标题: Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis
DOI: 10.1007/s11010-020-03759-x
发表时间: 2020-05-28
期刊: MOLECULAR AND CELLULAR BIOCHEMISTRY
影响因子: 2.795
货号: ZQ0449
产品名称: KYSE-510 cells
原文链接: https://link.springer.com/article/10.1007/s11010-020-03759-x


论文标题: β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT
DOI: 10.1016/j.acthis.2020.151538
发表时间: 2020-03-14
期刊: ACTA HISTOCHEMICA
影响因子: 2.107
货号: ZQ0449
产品名称: KYSE-150 cells

原文链接: https://www.sciencedirect.com/science/article/pii/S0065128120300374



PubMed=1728357; DOI=10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C
Shimada Y., Imamura M., Wagata T., Yamaguchi N., Tobe T.
Characterization of 21 newly established esophageal cancer cell lines.
Cancer 69:277-284(1992)


PubMed=7913084; DOI=10.1002/ijc.2910580224
Kanda Y., Nishiyama Y., Shimada Y., Imamura M., Nomura H., Hiai H., Fukumoto M.
Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines.
Int. J. Cancer 58:291-297(1994)


PubMed=9033652; DOI=10.1002/(SICI)1097-0215(19970207)70:4<437::AID-IJC11>3.0.CO;2-C
Tanaka H., Shimada Y., Imamura M., Shibagaki I., Ishizaki K.
Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines.
Int. J. Cancer 70:437-442(1997)


PubMed=11092977; DOI=10.1111/j.1349-7006.2000.tb00895.x
Pimkhaokham A., Shimada Y., Fukuda Y., Kurihara N., Imoto I., Yang Z.-Q., Imamura M., Nakamura Y., Amagasa T., Inazawa J.
Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon.
Jpn. J. Cancer Res. 91:1126-1133(2000)


PubMed=15172977; DOI=10.1158/0008-5472.CAN-04-0172
Sonoda I., Imoto I., Inoue J., Shibata T., Shimada Y., Chin K., Imamura M., Amagasa T., Gray J.W., Hirohashi S., Inazawa J.
Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
Cancer Res. 64:3741-3747(2004)


PubMed=16045545; DOI=10.1111/j.0959-9673.2005.00431.x
Ban S., Michikawa Y., Ishikawa K.-i., Sagara M., Watanabe K., Shimada Y., Inazawa J., Imai T.
Radiation sensitivities of 31 human oesophageal squamous cell carcinoma cell lines.
Int. J. Exp. Pathol. 86:231-240(2005)


PubMed=16832412; DOI=10.1038/sj.bjc.6603255
Tsunoda S., Okumura T., Ito T., Mori Y., Soma T., Watanabe G., Kaganoi J.-i., Itami A., Sakai Y., Shimada Y.
Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma.
Br. J. Cancer 95:322-330(2006)


PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)


PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)


PubMed=21191746; DOI=10.1007/s11684-010-0260-x
Ji J.-F., Wu K., Wu M., Zhan Q.-M.
p53 functional activation is independent of its genotype in five esophageal squamous cell carcinoma cell lines.
Front. Med. China 4:412-418(2010)


PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)



公司简介 / Company profile
上海中乔新舟生物科技有限公司
Shanghai Zhong Qiao Xin Zhou Biotechnology Co.,Ltd.
           上海中乔新舟生物科技有限公司(官网:www.zqxzbio.com)成立于2011年,历经...
联系我们 / Contact
电 话:021-56760357;021-56760351
传 真:
邮 箱:sales@zqxzbio.com
邮 编:200439
地 址:上海市宝山区长江南路180号
Copyright © 2014 ZQXZBIO All rights reserved.
技术支持:中乔新舟沪ICP备14008091号